Table 1.
Relationship between SNORA42 expression and the clinicopathological parameters of HCC patients.
| Characteristics | Pantients | SNORA42 level | p value | ||
|---|---|---|---|---|---|
| N = 60 | Low | High | |||
| Age (y) | <65 | 22 (36.7) | 12 | 10 | 0.395 |
| ≥65 | 38 (63.3) | 18 | 20 | ||
| Gender | Male | 39 (65.0) | 21 | 18 | 0.294 |
| Female | 21 (35.0) | 9 | 12 | ||
| AFP (μg/L) | <400 | 25 (41.7) | 13 | 12 | 0.500 |
| ≥400 | 35 (58.3) | 17 | 18 | ||
| Tumor size (cm) | <5 | 37 (61.7) | 17 | 20 | 0.298 |
| ≥5 | 23 (38.3) | 13 | 10 | ||
| HBV infection | No | 28 (46.7) | 12 | 16 | 0.219 |
| Yes | 32 (53.3) | 18 | 14 | ||
| Live cirrhosis | No | 23 (38.3) | 9 | 14 | 0.144 |
| Yes | 37 (61.7) | 21 | 16 | ||
| Microvascular invasion | No | 36 (60.0) | 22 | 14 | 0.032* |
| Yes | 24 (40.0) | 8 | 16 | ||